Trial Profile
A Phase 2 Open-Label, Parallel Group, Randomized, Dose-Finding Study to Assess the Efficacy and Safety of Intercostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 19 May 2012
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pacira BioSciences
- 03 Sep 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 16 Jun 2009 Actual initiation date (1 Dec 2008) added as reported by ClinicalTrials.gov.